Announced
Completed
Financials
Sources
Tags
Completed
biotechnology company
Biotechnology
Single Bidder
Poland
Cross Border
Private Equity
Acquisition
Private
Minority
Friendly
Synopsis
Investment firm Black Forest completed the investment in ExploRNA Therapeutics, a biotech spin-off company of the University of Warsaw that develops groundbreaking mRNA modification technologies. Financial terms were not disclosed. The investment by Black Forest SICAV-SIF will allow ExploRNA Therapeutics to develop and implement an ambitious research programme focusing on the use of mRNA for therapeutic purposes and enhancing the company’s research potential.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.